AnBogen Therapeutics

About:

Anbogen Therapeutics is a clinical-stage biotech company to creating breakthrough science that changes the life of cancer patients.

Website: https://www.anbogen.com

Top Investors: National Development Fund of Taiwan Government, KGI Venture Capital, China Development Industrial Bank (CDIB), Maxpro Ventures, TaiAn Technologies

Description:

Anbogen is a clinical-stage biotechnology company dedicated to developing precision anti-cancer drugs that hold the/promise of curing cancers and/or improving the lives of cancer patients worldwide.

Total Funding Amount:

$19.8M

Headquarters Location:

Nankang, T'ai-pei, Taiwan

Founded Date:

2019-01-01

Contact Email:

contact(AT)anbogen.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-07-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai